The Changing Epidemiology of Meningococcal Disease in Quebec, Canada, 1991–2011: Potential Implications of Emergence of New Strains
Open Access
- 29 November 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (11) , e50659
- https://doi.org/10.1371/journal.pone.0050659
Abstract
In order to inform meningococcal disease prevention strategies, we analysed the epidemiology of invasive meningococcal disease (IMD) in the province of Quebec, Canada, 10 years before and 10 years after the introduction of serogroup C conjugate vaccination. IMD cases reported to the provincial notifiable disease registry in 1991–2011 and isolates submitted for laboratory surveillance in 1997–2011 were analysed. Serogrouping, PCR testing and assignment of isolates to sequence types (ST) by using multilocus sequence typing (MLST) were performed. Yearly overall IMD incidence rates ranged from 2.2–2.3/100,000 in 1991–1992 to 0.49/100,000 in 1999–2000, increasing to 1.04/100,000 in 2011. Among the 945 IMD cases identified by laboratory surveillance in 1997–2011, 68%, 20%, 8%, and 3% were due to serogroups B, C, Y, and W135, respectively. Serogroup C IMD almost disappeared following the implementation of universal childhood immunization with monovalent C conjugate vaccines in 2002. Serogroup B has been responsible for 88% of all IMD cases and 61% of all IMD deaths over the last 3 years. The number and proportion of ST-269 clonal complex has been steadily increasing among the identified clonal complexes of serogroup B IMD since its first identification in 2003, representing 65% of serogroup B IMD in 2011. This clonal complex was first introduced in adolescent and young adults, then spread to other age groups. Important changes in the epidemiology of IMD have been observed in Quebec during the last two decades. Serogroup C has been virtually eliminated. In recent years, most cases have been caused by the serogroup B ST-269 clonal complex. Although overall burden of IMD is low, the use of a vaccine with potential broad-spectrum coverage could further reduce the burden of disease. Acceptability, feasibility and cost-effectiveness studies coupled with ongoing clinical and molecular surveillance are necessary in guiding public policy decisions.Keywords
This publication has 49 references indexed in Scilit:
- Invasive Serogroup B Neisseria meningitidis in Quebec, Canada, 2003 to 2010: Persistence of the ST-269 Clone Since It First Emerged in 2003Journal of Clinical Microbiology, 2012
- Changes in Serogroup and Genotype Prevalence Among Carried Meningococci in the United Kingdom During Vaccine ImplementationThe Journal of Infectious Diseases, 2011
- Population Structure and Capsular Switching of InvasiveNeisseria meningitidisIsolates in the Pre–Meningococcal Conjugate Vaccine Era—United States, 2000–2005The Journal of Infectious Diseases, 2010
- Characterization of fHbp , nhba ( gna2132 ), nadA , porA , Sequence Type (ST), and Genomic Presence of IS 1301 in Group B Meningococcal ST269 Clonal Complex Isolates from England and WalesJournal of Clinical Microbiology, 2009
- Meningococcal carriage and disease—Population biology and evolutionPublished by Elsevier ,2009
- Role of selection in the emergence of lineages and the evolution of virulence in Neisseria meningitidisProceedings of the National Academy of Sciences, 2008
- Molecular epidemiology of meningococcal disease in England and Wales 1975–1995, before the introduction of serogroup C conjugate vaccinesMicrobiology, 2008
- Invasive Meningococcal Disease in Québec, Canada, Due to an Emerging Clone of ST-269 Serogroup B Meningococci with Serotype Antigen 17 and Serosubtype Antigen P1.19 (B:17:P1.19)Journal of Clinical Microbiology, 2006
- Phenotypic and Genetic Characterization of a Unique Variant of Serogroup C ET-15 Meningococci (with the Antigenic Formula C:2a:P1.7,1) Causing Invasive Meningococcal Disease in Quebec, CanadaJournal of Clinical Microbiology, 2004
- The panmictic nature ofNeisseria meningitidisserogroup B during a period of endemic disease in CanadaCanadian Journal of Microbiology, 2001